Skip to main content

Roche Pharma Switzerland

The Roche Pharma division of Switzerland aims to realise holistic solutions in various areas of treatment, including prevention, diagnosis, and therapy as well as patient care.

Who we are

Roche Pharma (Switzerland) Ltd is the Swiss national subsidiary of Roche and its approximately 160 employees are responsible for ensuring that patients in Switzerland have access to Roche's innovative portfolio of medicines. The focus of the therapeutic areas is on oncology, rheumatology, pneumology, neurology, ophthalmology and rare diseases.

Pharma Switzerland

Our pharmaceuticals

Roche has brought many highly effective medicines to market. The focus of the therapeutic areas is on oncology, rheumatology, pneumology, neurology and rare diseases.

Pharma Switzerland

From molecule to medicine

Roche utilises cutting-edge technologies to create numerous new chemical compounds in the laboratory by combining known elements.

Pharma Switzerland

For patients and medical professionals

Living with an illness is a challenge for patients and those affected and raises many questions.

Pharma Switzerland

Patient Safety

All medicines can have adverse effects in addition to their benefits, such as headaches or nausea - known as side effects.